OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CARM1 arginine methyltransferase as a therapeutic target for cancer
Margarida A. Santos, Jee Won Hwang, Mark T. Bedford
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105124-105124
Open Access | Times Cited: 20

Showing 20 citing articles:

CARM1 phosphorylation at S595 by p38γ MAPK drives ROS-mediated cellular senescence
Yena Cho, Yong Kee Kim
Redox Biology (2024) Vol. 76, pp. 103344-103344
Open Access | Times Cited: 8

Biomedical Effects of Protein Arginine Methyltransferase Inhibitors
Mengtong Cao, Terry Nguyen, Jiabao Song, et al.
Journal of Biological Chemistry (2025) Vol. 301, Iss. 3, pp. 108201-108201
Open Access | Times Cited: 1

Chemical Proteomic Profiling of Protein Dopaminylation in Colorectal Cancer Cells
Nan Zhang, Shuaixin Gao, Haidong Peng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 7, pp. 2651-2660
Open Access | Times Cited: 6

Targeting hematological malignancies with isoxazole derivatives
Monika Majirská, Martina Bago Pilátová, Z Kudlicková, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104059-104059
Open Access | Times Cited: 5

Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma
Zhihao Liu, Min Lin, Chenyu Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6313-6326
Closed Access | Times Cited: 4

The emerging role of CARM1 in cancer
Zizhuo Xie, Yuan Tian, Xiaohan Guo, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1503-1522
Open Access | Times Cited: 4

Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets
Isabelle Rose Leo, Elena Kunold, Anastasia Audrey, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

CARM1 S217 phosphorylation by CDK1 in late G2 phase facilitates mitotic entry
Yena Cho, Dae‐Geun Song, Su‐Nam Kim, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, et al.
(2025) Vol. 2
Open Access

Loss of CARM1 alters the developmental programming of Glioma stem-like cells and creates a druggable NGFR/NTRK dependency
Dejauwne L. Young, Jennifer Aguilan, Ronald Cutler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Chemical proteomic profiling of protein dopaminylation in colorectal cancer cells
Nan Zhang, Shuaixin Gao, Haidong Peng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Protein arginine methyltransferase CARM1 in human breast cancer
Megan Bacabac, Peng Liu, Wei Xu
Endocrinology (2024) Vol. 165, Iss. 8
Closed Access | Times Cited: 1

USP4/CARM1 axis promotes the malignant transformation of breast cancer cells by upregulating SLC7A11 expression
Xin Li, Changjiao Yan, Jun Seop Yun, et al.
Clinical Breast Cancer (2024)
Closed Access | Times Cited: 1

Inhibiting Arginine Methylation
Gianluca Sbardella, Mark T. Bedford
Royal Society of Chemistry eBooks (2024), pp. 343-382
Closed Access

Proteoform-level deconvolution reveals a broader spectrum of ibrutinib off-targets
Isabelle Rose Leo, Elena Kunold, Anastasia Audrey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top